|
Originally published In Press as doi:10.1074/jbc.M411151200 on January 4, 2005
J. Biol. Chem., Vol. 280, Issue 11, 9895-9903, March 18, 2005
Bioluminescence Resonance Energy Transfer Reveals Ligand-induced Conformational Changes in CXCR4 Homo- and Heterodimers*
Yann Percherancier ,
Yamina A. Berchiche ¶,
Isabelle Slight ¶,
Rudolf Volkmer-Engert||,
Hirokazu Tamamura**,
Nobutaka Fujii**,
Michel Bouvier  , and
Nikolaus Heveker ¶
From the
Department of Biochemistry, Université de Montréal, Montréal H3C 3J7, Québéc, Canada, the ¶Research Centre/Hôpital Sainte-Justine, Montréal, Québec, H3T 1C5, Canada, the ||Institute for Medical Immunology, Department of Molecular Libraries, Charité-Universitätsmedizin, 10117 Berlin, Germany, and **Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto 606-8501, Japan
Homo- and heterodimerization have emerged as prominent features of G-protein-coupled receptors with possible impact on the regulation of their activity. Using a sensitive bioluminescence resonance energy transfer system, we investigated the formation of CXCR4 and CCR2 chemokine receptor dimers. We found that both receptors exist as constitutive homo- and heterodimers and that ligands induce conformational changes within the pre-formed dimers without promoting receptor dimer formation or disassembly. Ligands with different intrinsic efficacies yielded distinct bioluminescence resonance energy transfer modulations, indicating the stabilization of distinct receptor conformations. We also found that peptides derived from the transmembrane domains of CXCR4 inhibited activation of this receptor by blocking the ligand-induced conformational transitions of the dimer. Taken together, our data support a model in which chemokine receptor homo- and heterodimers form spontaneously and respond to ligand binding as units that undergo conformational changes involving both protomers even when only one of the two ligand binding sites is occupied.
Received for publication, September 29, 2004
, and in revised form, December 22, 2004.
* This work was supported in part by grants from the Canadian Institutes of Health Research (to N. H. and M. B.), the Canadian Foundation for Innovation, and the Fondation de l'Hôpital Sainte Justine. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Supported by the Institut National de la Santé et de la Recherche Médicale (INSERM, France) and the Canadian Institutes of Health Research.
 Canada Research Chair in Signal Transduction and Molecular Pharmacology.
 Recipient of a scholarship from the Fonds de la Recherche en Santé du Québéc. To whom correspondence should be addressed: Centre de Recherche, 6737 Hôpital Sainte-Justine, 3175 Chemin de la Côte Sainte-Catherine, Montréal, Québec, H3T 1C5, Canada. Tel.: 514-345-4931 (ext. 4190); Fax: 514-345-4801; E-mail: nikolaus.heveker{at}recherche-ste-justine.qc.ca.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Y. Percherancier, D. Germain-Desprez, F. Galisson, X. H. Mascle, L. Dianoux, P. Estephan, M. K. Chelbi-Alix, and M. Aubry
Role of SUMO in RNF4-mediated Promyelocytic Leukemia Protein (PML) Degradation: Sumoylation of pml and phospho-switch control of its sumo binding domain dissected in living cells
J. Biol. Chem.,
June 12, 2009;
284(24):
16595 - 16608.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Levoye, K. Balabanian, F. Baleux, F. Bachelerie, and B. Lagane
CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling
Blood,
June 11, 2009;
113(24):
6085 - 6093.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Kalatskaya, Y. A. Berchiche, S. Gravel, B. J. Limberg, J. S. Rosenbaum, and N. Heveker
AMD3100 Is a CXCR7 Ligand with Allosteric Agonist Properties
Mol. Pharmacol.,
May 1, 2009;
75(5):
1240 - 1247.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. E. Luker, M. Gupta, and G. D. Luker
Imaging chemokine receptor dimerization with firefly luciferase complementation
FASEB J,
March 1, 2009;
23(3):
823 - 834.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Wong and W. Korz
Translating an Antagonist of Chemokine Receptor CXCR4: From Bench to Bedside
Clin. Cancer Res.,
December 15, 2008;
14(24):
7975 - 7980.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. N. Hartmann, V. Grabovsky, R. Pasvolsky, Z. Shulman, E. C. Buss, A. Spiegel, A. Nagler, T. Lapidot, M. Thelen, and R. Alon
A crosstalk between intracellular CXCR7 and CXCR4 involved in rapid CXCL12-triggered integrin activation but not in chemokine-triggered motility of human T lymphocytes and CD34+ cells
J. Leukoc. Biol.,
October 1, 2008;
84(4):
1130 - 1140.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Lagane, K. Y. C. Chow, K. Balabanian, A. Levoye, J. Harriague, T. Planchenault, F. Baleux, N. Gunera-Saad, F. Arenzana-Seisdedos, and F. Bachelerie
CXCR4 dimerization and {beta}-arrestin-mediated signaling account for the enhanced chemotaxis to CXCL12 in WHIM syndrome
Blood,
July 1, 2008;
112(1):
34 - 44.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. C. Y. Choi, J. Simon, K. W. K. Tsim, and E. A. Barnard
Constitutive and Agonist-induced Dimerizations of the P2Y1 Receptor: RELATIONSHIP TO INTERNALIZATION AND SCAFFOLDING
J. Biol. Chem.,
April 18, 2008;
283(16):
11050 - 11063.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Kern, D. Hubbard, A. Amano, and G. D. Bryant-Greenwood
Cloning, Expression, and Functional Characterization of Relaxin Receptor (Leucine-Rich Repeat-Containing G Protein-Coupled Receptor 7) Splice Variants from Human Fetal Membranes
Endocrinology,
March 1, 2008;
149(3):
1277 - 1294.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Sohy, M. Parmentier, and J.-Y. Springael
Allosteric Transinhibition by Specific Antagonists in CCR2/CXCR4 Heterodimers
J. Biol. Chem.,
October 12, 2007;
282(41):
30062 - 30069.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Sierro, C. Biben, L. Martinez-Munoz, M. Mellado, R. M. Ransohoff, M. Li, B. Woehl, H. Leung, J. Groom, M. Batten, et al.
Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7
PNAS,
September 11, 2007;
104(37):
14759 - 14764.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Tadagaki, K. Yamanishi, and Y. Mori
Reciprocal roles of cellular chemokine receptors and human herpesvirus 7-encoded chemokine receptors, U12 and U51
J. Gen. Virol.,
May 1, 2007;
88(5):
1423 - 1428.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Guyon and J.-L. Nahon
Multiple actions of the chemokine stromal cell-derived factor-1{alpha} on neuronal activity
J. Mol. Endocrinol.,
March 1, 2007;
38(3):
365 - 376.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. A. Berchiche, K. Y. Chow, B. Lagane, M. Leduc, Y. Percherancier, N. Fujii, H. Tamamura, F. Bachelerie, and N. Heveker
Direct Assessment of CXCR4 Mutant Conformations Reveals Complex Link between Receptor Structure and G{alpha}i Activation
J. Biol. Chem.,
February 23, 2007;
282(8):
5111 - 5115.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Gaibelet, T. Planchenault, S. Mazeres, F. Dumas, F. Arenzana-Seisdedos, A. Lopez, B. Lagane, and F. Bachelerie
CD4 and CCR5 Constitutively Interact at the Plasma Membrane of Living Cells: A CONFOCAL FLUORESCENCE RESONANCE ENERGY TRANSFER-BASED APPROACH
J. Biol. Chem.,
December 8, 2006;
281(49):
37921 - 37929.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Wang, L. He, C. A. Combs, G. Roderiquez, and M. A. Norcross
Dimerization of CXCR4 in living malignant cells: control of cell migration by a synthetic peptide that reduces homologous CXCR4 interactions.
Mol. Cancer Ther.,
October 1, 2006;
5(10):
2474 - 2483.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Jiang, L. Betancourt, and R. G. Smith
Ghrelin Amplifies Dopamine Signaling by Cross Talk Involving Formation of Growth Hormone Secretagogue Receptor/Dopamine Receptor Subtype 1 Heterodimers
Mol. Endocrinol.,
August 1, 2006;
20(8):
1772 - 1785.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-Y. Springael, P. N. Le Minh, E. Urizar, S. Costagliola, G. Vassart, and M. Parmentier
Allosteric Modulation of Binding Properties between Units of Chemokine Receptor Homo- and Hetero-Oligomers
Mol. Pharmacol.,
May 1, 2006;
69(5):
1652 - 1661.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Belmadani, P. B. Tran, D. Ren, and R. J. Miller
Chemokines regulate the migration of neural progenitors to sites of neuroinflammation.
J. Neurosci.,
March 22, 2006;
26(12):
3182 - 3191.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Guo, L. Shi, M. Filizola, H. Weinstein, and J. A. Javitch
From The Cover: Crosstalk in G protein-coupled receptors: Changes at the transmembrane homodimer interface determine activation
PNAS,
November 29, 2005;
102(48):
17495 - 17500.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. S. Kearn, K. Blake-Palmer, E. Daniel, K. Mackie, and M. Glass
Concurrent Stimulation of Cannabinoid CB1 and Dopamine D2 Receptors Enhances Heterodimer Formation: A Mechanism for Receptor Cross-Talk?
Mol. Pharmacol.,
May 1, 2005;
67(5):
1697 - 1704.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|